FI43435C - For the preparation of therapeutically active alpha-halomethyl-1-chlorobenzoyl-3-indolylate mixture - Google Patents

For the preparation of therapeutically active alpha-halomethyl-1-chlorobenzoyl-3-indolylate mixture

Info

Publication number
FI43435C
FI43435C FI43435DA FI43435C FI 43435 C FI43435 C FI 43435C FI 43435D A FI43435D A FI 43435DA FI 43435 C FI43435 C FI 43435C
Authority
FI
Finland
Prior art keywords
indolylate
halomethyl
chlorobenzoyl
mixture
preparation
Prior art date
Application number
Other languages
Finnish (fi)
Inventor
Shen Tsung-Ying
Sarett Lewis Hastings
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of FI43435C publication Critical patent/FI43435C/en

Links

FI43435D 1963-09-05 1963-09-05 For the preparation of therapeutically active alpha-halomethyl-1-chlorobenzoyl-3-indolylate mixture FI43435C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI43435T 1963-09-05

Publications (1)

Publication Number Publication Date
FI43435C true FI43435C (en) 1971-04-13

Family

ID=36904814

Family Applications (1)

Application Number Title Priority Date Filing Date
FI43435D FI43435C (en) 1963-09-05 1963-09-05 For the preparation of therapeutically active alpha-halomethyl-1-chlorobenzoyl-3-indolylate mixture

Country Status (1)

Country Link
FI (1) FI43435C (en)

Similar Documents

Publication Publication Date Title
FI42712C (en) Process for the preparation of therapeutically active biphenylalkane derivatives
FI48590C (en) Process for the preparation of therapeutically useful azaspiroalkandion compounds.
SE383878B (en) PROCEDURE FOR PREPARATION OF PGF-TYPE THERAPEUTICALLY ACTIVE PROSTAGLAND ASSOCIATIONS
SE300618B (en) Process for the preparation of N-phenylpropyl-N1 -phenylpiperazines
FI47365C (en) Process for the preparation of new therapeutically active indolder t.
FI46961C (en) Process for the preparation of therapeutically active 5-nitroimidazole bamates
FI41394C (en) Process for the preparation of therapeutically active N-substituted I-aminoindan derivatives
FI47881C (en) Process for the preparation of therapeutically active substituted phenylacetamides
FI47189C (en) Process for the preparation of therapeutically active d-lysergic acid-N-phenylpiperazides.
FI47100C (en) Process for the preparation of therapeutically active 1-p-chlorobenzoyl-2-lower-alkyl-5-lower-alkoxy-3-indolyl-acetic acid.
FI43435C (en) For the preparation of therapeutically active alpha-halomethyl-1-chlorobenzoyl-3-indolylate mixture
FI46963C (en) Process for the preparation of antidiabetically active sulfonamides
FI45954C (en) Process for the preparation of therapeutically active benzenesulfonylcuramides.
FI43994C (en) Process for the preparation of new therapeutically active 1,2-diaryl-4-alkyl-3,5-dioxopyrazolidines
FI42324C (en) For the preparation of therapeutically active 10-aminoalkyl-dibenzocycloheptatrienders
FI50879C (en) Process for the preparation of therapeutically active substituted 3-aminoacylamino-thiophenes.
FI48081C (en) Process for the preparation of pharmacologically active 1-sulfanilyl-2-in mino-3-R-imidazolidines
FI44595C (en) For the preparation of therapeutically active para-N-acylaminophenylsalicylic acid
FI40011C (en) For the preparation of therapeutically active benzoquinolizine derivatives
FI41549C (en) For the preparation of therapeutically active (alpha-methylenacyl) -naphthyloxy derivatives
FI43997C (en) Process for the preparation of therapeutically active imidazoline derivatives
FI40287C (en) For the preparation of therapeutically active 2-flask substituents 17-oxide-A-nor-5alpha-androstan-2-ol or ester
FI41159C (en) For the preparation of therapeutically active substances indolyl- (3) -alkanecarbonsyrraestrar
FI44405C (en) For the preparation of therapeutically active 4-substituents 1,2-diphenyl-3,5-dioxypyrazolidiner
FI44408C (en) Process for the preparation of therapeutically active imidazoline derivatives